Rene Russo - 21 Oct 2021 Form 3 Insider Report for Xilio Therapeutics, Inc. (XLO)

Role
CEO and President, Director, 10%+ Owner
Signature
/s/ Chris Frankenfield, Attorney-in-Fact
Issuer symbol
XLO
Transactions as of
21 Oct 2021
Net transactions value
$0
Form type
3
Filing time
21 Oct 2021, 20:45:59 UTC
Previous filing
09 Aug 2021
Next filing
04 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XLO Common Stock 200,633 21 Oct 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XLO Stock Option (right to buy) 21 Oct 2021 Common Stock 170,831 $5.51 Direct F1
holding XLO Stock Option (right to buy) 21 Oct 2021 Common Stock 68,872 $5.51 Direct F2
holding XLO Stock Option (right to buy) 21 Oct 2021 Common Stock 473,334 $5.89 Direct F3
holding XLO Stock Option (right to buy) 21 Oct 2021 Common Stock 135,134 $11.69 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on July 23, 2020 for 170,831 shares. The shares underlying the option began vesting on March 12, 2020 and shall vest in equal monthly installments thereafter until February 12, 2024.
F2 The option was granted on July 23, 2020 for 68,872 shares. The shares underlying the option began vesting on May 15, 2019 and shall vest in equal monthly installments thereafter until April 15, 2023.
F3 The option was granted on March 11, 2021 for 473,334 shares. The shares underlying the option began vesting on April 1, 2021 and shall vest in equal monthly installments thereafter until March 1, 2025.
F4 The option was granted on August 23, 2021 for 135,134 shares. The shares underlying the option began vesting on September 1, 2021 and shall vest in equal monthly installments thereafter until August 1, 2025.

Remarks:

Exhibit Index: 24.1 Power of Attorney